Lynnette Ferguson

Personal Home Page

http://www.nutrigenomics.org.nz/index/page/151

Articles in Scholarly Journals [Incomplete List]

  1. Nutrition and Mutagenesis
    Annual Review of Nutrition, vol. 28, no. 1, pp. 313–329, 2008
  2. Triallelic Single Nucleotide Polymorphisms and Genotyping Error in Genetic Epidemiology Studies: MDR1 (ABCB1) G2677/T/A as an Example
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 6, pp. 1185–1192, 2007
  3. Has Toll-Like Receptor 4 Been Prematurely Dismissed as an Inflammatory Bowel Disease Gene? Association Study Combined With Meta-Analysis Shows Strong Evidence for Association
    The American Journal of Gastroenterology, vol. 102, no. 11, pp. 2504–2512, 2007
  4. Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts
    Journal of Medical Genetics, vol. 45, no. 1, pp. 36–42, 2007
  5. Modeling inflammatory bowel disease: the zebrafish as a way forward
    Expert Review of Molecular Diagnostics, vol. 7, no. 2, pp. 177–193, 2007
  6. Cancer Prevention by Dietary Bioactive Components that Target the Immune Response
    Current Cancer Drug Targets, vol. 7, no. 5, pp. 459–464, 2007
  7. Association ofDLG5 variants with inflammatory bowel disease in the New Zealand caucasian population and meta-analysis of the DLG5 R30Q variant
    Inflammatory Bowel Diseases, vol. 13, no. 9, pp. 1069–1076, 2007
  8. Nutrigenomics in the whole-genome scanning era: Crohn’s disease as example
    Cellular and Molecular Life Sciences, vol. 64, no. 23, pp. 3105–3118, 2007
  9. Uncoupling gene–diet interactions in inflammatory bowel disease (IBD)
    Genes & Nutrition, vol. 2, no. 1, pp. 71–73, 2007
  10. Nutrigenomics and gut health: meeting report from an international conference in Auckland, New Zealand, April 30, May 1–3, 2006
    Genes & Nutrition, vol. 2, no. 1, pp. 157–160, 2007
  11. Non-covalent ligand/DNA interactions: Minor groove binding agents
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 623, no. 1-2, pp. 24–40, 2007
  12. Genotoxicity of non-covalent interactions: DNA intercalators
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 623, no. 1-2, pp. 14–23, 2007
  13. Genetic variation in human disease and a new role for copy number variants
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 622, no. 1-2, pp. 33–41, 2007
  14. Cell culture models in developing nutrigenomics foods for inflammatory bowel disease
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 622, no. 1-2, pp. 94–102, 2007
  15. Nutrigenomics and gut health
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 622, no. 1-2, pp. 1–6, 2007
  16. Genes, diet and inflammatory bowel disease
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 622, no. 1-2, pp. 70–83, 2007
  17. Kiwifruit consumption reduces DNA fragility: a randomized controlled pilot study in volunteers
    Nutrition Research, vol. 26, no. 5, pp. 197–201, 2006
  18. The role of the Therapeutic Goods Administration and the Medicine and Medical Devices Safety Authority in evaluating complementary and alternative medicines in Australia and New Zealand
    Toxicology, vol. 221, no. 1, pp. 88–94, 2006
  19. Kiwifruit, your health partner
    Phytothérapie, vol. 4, no. 2, pp. 87–92, 2006
  20. Frameshift mutations induced by four isomeric nitroacridines and their des-nitro counterpart in thelacZ reversion assay inEscherichia coli
    Environmental and Molecular Mutagenesis, vol. 47, no. 2, pp. 82–94, 2006
  21. Antioxidant and antigenotoxic effects of plant cell wall hydroxycinnamic acids in cultured HT-29 cells
    Molecular Nutrition & Food Research, vol. 49, no. 6, pp. 585–593, 2005
  22. Dietary fibres as “prebiotics”: Implications for colorectal cancer
    Molecular Nutrition & Food Research, vol. 49, no. 6, pp. 609–619, 2005
  23. Production and characterisation of two wheat-bran fractions: an aleurone-rich and a pericarp-rich fraction
    Molecular Nutrition & Food Research, vol. 49, no. 6, pp. 536–545, 2005
  24. Dietary Fibres and Human Health
    Molecular Nutrition & Food Research, vol. 49, no. 6, pp. 517–517, 2005
  25. Interlaboratory validation of a CD71-based flow cytometric method (Microflow�) for the scoring of micronucleated reticulocytes in mouse peripheral blood
    Environmental and Molecular Mutagenesis, vol. 45, no. 1, pp. 44–55, 2005
  26. Chemical Research in Toxicology, vol. 18, no. 2, pp. 239–248, 2005
  27. Overview of mechanisms of cancer chemopreventive agents
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 591, no. 1-2, pp. 8–15, 2005
  28. Multiple drug resistance, antimutagenesis and anticarcinogenesis
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 591, no. 1-2, pp. 24–33, 2005
  29. Mechanistic approaches to chemoprevention of mutation and cancer
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 591, no. 1-2, pp. 3–7, 2005
  30. Does a diet rich in dietary fibre really reduce the risk of colon cancer?
    Digestive and Liver Disease, vol. 37, no. 3, pp. 139–141, 2005
  31. The case for strategic international alliances to harness nutritional genomics for public and personal health
    British Journal of Nutrition , vol. 94, no. 5, pp. 623–632, 2005
  32. Cell & Chromosome, vol. 3, no. 1, p. 2, 2004
  33. Mechanisms by which resistant starches and non-starch polysaccharide sources affect the metabolism and disposition of the food carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline
    Journal of Chromatography B, vol. 802, no. 1, pp. 201–210, 2004
  34. Immunonutrition and cancer
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 551, no. 1-2, pp. 29–42, 2004
  35. Nutrition and carcinogenesis
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 551, no. 1-2, pp. 1–8, 2004
  36. Dietary cancer and prevention using antimutagens
    Toxicology, vol. 198, no. 1-3, pp. 147–159, 2004
  37. Journal of Agricultural and Food Chemistry, vol. 52, no. 6, pp. 1511–1513, 2004
  38. Epigenetic events and protection from colon cancer in New Zealand
    Environmental and Molecular Mutagenesis, vol. 44, no. 1, pp. 36–43, 2004
  39. Enhanced coloration reveals high antioxidant potential in new sweetpotato cultivars
    Journal of the Science of Food and Agriculture, vol. 83, no. 10, pp. 1076–1082, 2003
  40. Effect of smoking habit on the frequency of micronuclei in human lymphocytes: results from the Human MicroNucleus project
    Mutation Research/Reviews in Mutation Research, vol. 543, no. 2, pp. 155–166, 2003
  41. Contrasting effects of non-starch polysaccharide and resistant starch-based diets on the disposition and excretion of the food carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), in a rat model
    Food and Chemical Toxicology, vol. 41, no. 6, pp. 785–792, 2003
  42. The 10 basic requirements for a scientific paper reporting antioxidant, antimutagenic or anticarcinogenic potential of test substances in in vitro experiments and animal studies in vivo
    Food and Chemical Toxicology, vol. 41, no. 5, pp. 603–610, 2003
  43. Intra- and inter-laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes Results of an international slide-scoring exercise by the HUMN project
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 534, no. 1-2, pp. 45–64, 2003
  44. Erratum to “Intra and inter-laboratory variation in the scoring of micronucici and nucleoplasmic bridges in binucleated human lymphocytes Results of an international slide-scoring exercise by the HUMN project” [Mutat. Res. 534 (2002) 45–64]
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 538, no. 1-2, pp. 185–186, 2003
  45. Dietary and medicinal antimutagens and anticarcinogens: molecular mechanisms and chemopreventive potential—highlights of a symposium
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 523-524, pp. 1–8, 2003
  46. Potential functional foods in the traditional Maori diet
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 523-524, pp. 109–117, 2003
  47. The dietary fibre debate: more food for thought
    The Lancet, vol. 361, no. 9368, pp. 1487–1488, 2003
  48. Bacterial antimutagenesis by hydroxycinnamic acids from plant cell walls
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 542, no. 1-2, pp. 49–58, 2003
  49. Highlights of the Eighth International Conference on Carcinogenic/Mutagenic N-Substituted Aryl Compounds
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 506-507, pp. 1–8, 2002
  50. Meat consumption, cancer risk and population groups within New Zealand
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 506-507, pp. 215–224, 2002
  51. Natural and human-made mutagens and carcinogens in the human diet
    Toxicology, vol. 181-182, pp. 79–82, 2002
  52. Kiwifruit promotes laxation in the elderly
    Asia Pacific Journal of Clinical Nutrition, vol. 11, no. 2, pp. 164–168, 2002
  53. Anti-Cancer Drugs, vol. 13, no. 3, pp. 271–280, 2002
  54. Changing Concepts of Dietary Fiber: Implications for Carcinogenesis
    Nutrition and Cancer, vol. 39, no. 2, pp. 155–169, 2001
  55. Antimutagenesis/anticarcinogenesis 2001: screening, methods and biomarkers
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 496, no. 1-2, pp. 1–4, 2001
  56. Anti-Cancer Drugs, vol. 12, no. 8, pp. 683–690, 2001
  57. Vitamins/minerals and genomic stability in humans
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 475, no. 1-2, pp. 1–6, 2001
  58. Role of plant polyphenols in genomic stability
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 475, no. 1-2, pp. 89–111, 2001
  59. Antimutagenesis/anticarcinogenesis 2001: mechanistic studies
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 480-481, pp. 1–7, 2001
  60. Contrasting effects of acute and chronic dietary exposure to 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) on xenobiotic metabolising enzymes in the male Fischer 344 Rat: implications for chemoprevention studies
    European Journal of Nutrition, vol. 40, no. 1, pp. 39–47, 2001
  61. Analysis for loss of heterozygosity (LOH) of p53 allele in tumors derived from p53+/? and CD-1 mice following repeated subcutaneous injections of solutions containing antioxidants
    Environmental and Molecular Mutagenesis, vol. 37, no. 1, pp. 27–30, 2001
  62. Flow cytometric enumeration of micronucleated reticulocytes: High transferability among 14 laboratories
    Environmental and Molecular Mutagenesis, vol. 38, no. 1, pp. 59–68, 2001
  63. Effects of two contrasting dietary fibres on starch digestion, short-chain fatty acid production and transit time in rats
    Journal of the Science of Food and Agriculture, vol. 80, no. 14, pp. 2089–2095, 2000
  64. Transcriptional blockages in a cell-free system by sequence-selective DNA alkylating agents
    Chemico-Biological Interactions, vol. 126, no. 1, pp. 15–31, 2000
  65. Antimutagenic effects of wheat bran diet through modification of xenobiotic metabolising enzymes
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 454, no. 1-2, pp. 77–88, 2000
  66. Editorial
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 455, no. 1-2, pp. 1–2, 2000
  67. The study of antigenotoxic effects of dietary fibre is lost in a confused concept
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 447, no. 2, pp. 319–322, 2000
  68. Mutations induced by some DNA minor groove binding alkylators in AS52 Chinese hamster cells
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 448, no. 1, pp. 35–45, 2000
  69. The mutagenic spectrum of acridine-linked aniline nitrogen mustards in AS52 cells: implications of DNA targeting with high selectivity for adenine or guanine bases
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 469, no. 1, pp. 115–126, 2000
  70. Comparative Effects of Three Resistant Starch Preparations on Transit Time and Short-Chain Fatty Acid Production in Rats
    Nutrition and Cancer, vol. 36, no. 2, pp. 230–237, 2000
  71. Studies on the mechanism of cancer protection by wheat bran: effects on the absorption, metabolism and excretion of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)
    Carcinogenesis, vol. 20, no. 12, pp. 2253–2260, 1999
  72. Antimutagens in food plants eaten by polynesians: micronutrients, phytochemicals and protection against bacterial mutagenicity of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline
    Food and Chemical Toxicology, vol. 37, no. 2-3, pp. 95–103, 1999
  73. Editorial
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 443, no. 1-2, pp. 1–10, 1999
  74. Dietary fibres may protect or enhance carcinogenesis
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 443, no. 1-2, pp. 95–110, 1999
  75. Prospects for cancer prevention
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 428, no. 1-2, pp. 329–338, 1999
  76. Adsorption of a hydrophobic mutagen to cereal brans and cereal bran dietary fibres
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 412, no. 3, pp. 323–331, 1998
  77. Mutagenic properties of topoisomerase-targeted drugs
    Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol. 1400, no. 1-3, pp. 213–222, 1998
  78. Effect of selected antimutagens on the genotoxicity of antitumor agents
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 402, no. 1-2, pp. 289–298, 1998
  79. Comparative mutational spectra of the nitrogen mustard chlorambucil and its half-mustard analogue in Chinese hamster AS52 cells
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 401, no. 1-2, pp. 153–164, 1998
  80. Inhibitors of topoisomerase II enzymes: a unique group of environmental mutagens and carcinogens
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 400, no. 1-2, pp. 271–278, 1998
  81. Suberized plant cell walls suppress formation of heterocyclic amine-induced aberrant crypts in a rat model
    Chemico-Biological Interactions, vol. 114, no. 3, pp. 191–209, 1998
  82. Amsacrine-induced mutations in AS52 cells
    Environmental and Molecular Mutagenesis, vol. 32, no. 1, pp. 47–55, 1998
  83. Does wheat bran or does wheat dietary fibre protect against breast cancer?
    International Journal of Cancer, vol. 78, no. 3, pp. 385–386, 1998
  84. In vivo effects of chlorophyllin on the antitumour agent cyclophosphamide
    International Journal of Cancer, vol. 70, no. 1, pp. 84–89, 1997
  85. Particle Size of Wheat Bran in Relation to Colonic Function in Rats1
    Lebensmittel-Wissenschaft und-Technologie, vol. 30, no. 7, pp. 735–742, 1997
  86. Overlap between mutagens and teratogens
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 396, no. 1-2, pp. 1–8, 1997
  87. Micronutrients, dietary questionnaires and cancer
    Biomedecine & Pharmacotherapy, vol. 51, no. 8, pp. 337–344, 1997
  88. Modulation of the potency of promutagens and direct acting mutagens in bacteria by inhibitors of the multidrug resistance mechanism
    Mutagenesis, vol. 12, no. 6, pp. 431–435, 1997
  89. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine
    Environmental and Molecular Mutagenesis, vol. 27, no. 4, pp. 255–262, 1996
  90. Aneuploidy in germ cells: Etiologies and risk factors
    Environmental and Molecular Mutagenesis, vol. 28, no. 3, pp. 159–166, 1996
  91. Meiotic recombination and germ cell aneuploidy
    Environmental and Molecular Mutagenesis, vol. 28, no. 3, pp. 192–210, 1996
  92. The adsorption of heterocyclic aromatic amines by model dietary fibres with contrasting compositions
    Chemico-Biological Interactions, vol. 100, no. 1, pp. 13–25, 1996
  93. Studies on the role of specific dietary fibres in protection against colorectal cancer
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 350, no. 1, pp. 173–184, 1996
  94. The clinical use of mutagenic anticancer drugs
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 355, no. 1-2, pp. 1–12, 1996
  95. Mutagenic and carcinogenic properties of platinum-based anticancer drugs
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 355, no. 1-2, pp. 59–70, 1996
  96. Mutagenicity of anticancer drugs that inhibit topoisomerase enzymes
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 355, no. 1-2, pp. 91–101, 1996
  97. The effects of a soluble-fibre polysaccharide on the adsorption of carcinogens to insoluble dietary fibres
    Chemico-Biological Interactions, vol. 95, no. 3, pp. 245–255, 1995
  98. Microbial mutagenic effects of the DNA minor groove binder pibenzimol (Hoechst 33258) and a series of mustard analogues
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 329, no. 1, pp. 19–27, 1995
  99. Anticancer drugs: an underestimated risk or an underutilised resource in mutagenesis?
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 331, no. 1, pp. 1–26, 1995
  100. Synthesis, DNA interactions and biological activity of DNA minor groove targeted polybenzamide-linked nitrogen mustards
    Bioorganic & Medicinal Chemistry, vol. 3, no. 6, pp. 679–691, 1995
  101. DNA-directed aniline mustards with high selectivity for adenine or guanine bases: mutagenesis in a variety of Salmonella typhimurium strains differing in DNA-repair capability
    Mutation Research/Genetic Toxicology, vol. 321, no. 1-2, pp. 27–34, 1994
  102. Antimutagens as cancer chemopreventive agents in the diet
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 307, no. 1, pp. 395–410, 1994
  103. Topoisomerase II enzymes and mutagenicity
    Environmental and Molecular Mutagenesis, vol. 24, no. 4, pp. 245–261, 1994
  104. Introduction
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 290, no. 1, p. 1, 1993
  105. Dietary fibre: its composition and role in protection against colorectal cancer
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 290, no. 1, pp. 97–110, 1993
  106. Diet and the prevention of colorectal cancer
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 290, no. 1, pp. 139–143, 1993
  107. Multidrug resistance and mutagenesis
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 285, no. 1, pp. 79–90, 1993
  108. Induction of mitotic crossing-over by the topoisomerase II poison DACA (N-[2-dimethylamino)ethyl]acridine-4-carboxamide) in Saccharomyces cerevisiae
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 289, no. 2, pp. 157–163, 1993
  109. The size of cytokinesis-blocked micronuclei in human peripheral blood lymphocytes as a measure of aneuploidy induction by Set A compounds in the EEC trial
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 287, no. 1, pp. 101–112, 1993
  110. The adsorption of a range of dietary carcinogens by α-cellulose, a model insoluble dietary fiber
    Mutation Research/Genetic Toxicology, vol. 319, no. 4, pp. 257–266, 1993
  111. Mouse micronucleus assays of sporidesmin, the toxin associated with facial eczema in ruminants
    Mutation Research Letters, vol. 302, no. 1, pp. 71–74, 1993
  112. Mutagenic activities of azido analogues of amsacrine and other 9-anilinoacridines in Salmonella typhimurium and their enhancement by photoirradiation
    Mutation Research/Genetic Toxicology, vol. 280, no. 4, pp. 233–244, 1992
  113. Induction of the cytoplasmic 'petite' mutation by chemical and physical agents in Saccharomyces cerevisiae
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 265, no. 1, pp. 103–148, 1992
  114. Modulation of mutagenic properties in a series of DNA-directed alkylating agents by variation of chain length and alkylator reactivity
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 265, no. 2, pp. 181–193, 1992
  115. Chromosomal changes in Chinese hamster AA8 cells caused by podophyllin, a common treatment for genital warts
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 266, no. 2, pp. 231–239, 1992
  116. In vitro and in vivo mutagenicity studies on sporidesmin, the toxin associated with facial eczema in ruminants
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 268, no. 2, pp. 199–210, 1992
  117. In vitro adsorption of a hydrophobic mutagen to gastrointestinal mucus glycoprotein (mucin) and dietary fibre
    Chemico-Biological Interactions, vol. 82, no. 2, pp. 219–229, 1992
  118. The genetic toxicology of acridines
    Mutation Research/Reviews in Genetic Toxicology, vol. 258, no. 2, pp. 123–160, 1991
  119. Adsorption of a hydrophobic mutagen to dietary fibre from the skin and flesh of potato tubers
    Mutation Research/Genetic Toxicology, vol. 260, no. 2, pp. 203–213, 1991
  120. Adsorption of a hydrophobic mutagen to five contrasting dietary fiber preparations
    Mutation Research Letters, vol. 262, no. 3, pp. 195–202, 1991
  121. Stimulation of bacterial mutagenicity by inhibitors of mammalian cell multidrug resistance
    Mutation Research Letters, vol. 264, no. 4, pp. 231–234, 1991
  122. Variation in the mutagenic potential of acridines in Salmonella typhimurium, with stage of the culture
    Mutation Research Letters, vol. 262, no. 4, pp. 227–231, 1991
  123. Effects of bile salts on the adsorption of a hydrophobic mutagen to dietary fiber
    Mutation Research Letters, vol. 245, no. 2, pp. 111–117, 1990
  124. Direct-acting mutagenic properties of some hair dyes used in New Zealand
    Mutation Research Letters, vol. 245, no. 1, pp. 41–46, 1990
  125. A model system for studying the adsorption of a hydrophobic mutagen to dietary fibre
    Mutation Research Letters, vol. 244, no. 2, pp. 173–178, 1990
  126. Mutagenic and recombinogenic consequences of DNA-repair inhibition during treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea in Saccharomyces cerevisiae
    Mutation Research/Genetic Toxicology, vol. 241, no. 4, pp. 369–377, 1990
  127. Genetic toxicology of tricyclic carboxamides, a new class of DNA binding antitumour agent
    European Journal of Cancer and Clinical Oncology, vol. 26, no. 6, pp. 709–714, 1990
  128. Protection by inhibitors of multidrug resistance against mitochondrial mutagenesis in Saccharomyces cerevisiae
    European Journal of Cancer and Clinical Oncology, vol. 26, no. 1, pp. 55–60, 1990
  129. Structure-activity relationships for the mutagenic activity of tricyclic intercalating agents in Salmonella typhimurium
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 232, no. 2, pp. 233–241, 1990
  130. The mutagenic effects of diacridines and diquinolines in microbial systems
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 232, no. 2, pp. 337–343, 1990
  131. 'Petite' mutagenesis and mitotic crossing-over in yeast by DNA-targeted alkylating agents
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 215, no. 2, pp. 213–222, 1989
  132. A possible mechanism of toxicity by the antidepressant amoxapine based on its effects in three in vitro models
    Toxicology in Vitro, vol. 3, no. 4, pp. 285–291, 1989
  133. Mutagenicity profiles of newer amsacrine analogues with activity against solid tumours: Comparison of microbial and mammalian systems
    European Journal of Cancer and Clinical Oncology, vol. 25, no. 2, pp. 255–261, 1989
  134. Relationships between structure, toxicity and genetic effects in Salmonella typhimurium and Saccharomyces cerevisiae for substituted aniline mustards
    Mutation Research/Genetic Toxicology, vol. 224, no. 1, pp. 95–104, 1989
  135. Mutagenic activity of nitracrine derivatives in Salmonella typhimurium: Relationship to drug physicochemical parameters, and to bacterial uvrB and recA genes and plasmid pKM101
    Mutation Research/Genetic Toxicology, vol. 223, no. 1, pp. 13–22, 1989
  136. Verapamil as a co-mutagen in the Salmonella/mammalian microsome mutagenicity test
    Mutation Research Letters, vol. 209, no. 1-2, pp. 57–62, 1988
  137. 'Petite' mutagenesis by anticancer drugs in Saccharomyces cerevisiae
    European Journal of Cancer and Clinical Oncology, vol. 24, no. 4, pp. 591–596, 1988
  138. Biochemical evidence that high concentrations of the antidepressant amoxapine may cause inhibition of mitochondrial electron transport
    Toxicology and Applied Pharmacology, vol. 93, no. 1, pp. 118–126, 1988
  139. Comparison of the mutagenicity of amsacrine with that of a new clinical analogue, CI-921
    Mutation Research/Genetic Toxicology, vol. 204, no. 2, pp. 207–217, 1988
  140. Mitotic crossing-over by anticancer drugs in Saccharomyces cerevisiae strain D5
    Mutation Research/Genetic Toxicology, vol. 204, no. 2, pp. 239–249, 1988
  141. Mutagenic, recombinogenic and antimitochondrial effects of nitracrine analogues in Saccharomyces cerevisiae
    Mutation Research/Genetic Toxicology, vol. 187, no. 4, pp. 209–217, 1987
  142. Mutagenicity of nitracrine analogues in Salmonella typhimurium: Mutational specificity and activation by bacterial enzymes and rat-liver S9
    Mutation Research/Genetic Toxicology, vol. 187, no. 1, pp. 1–9, 1987
  143. Frameshift mutagenesis by nitracrine analogues in wild-type, uvrB, polA and recA strains of Salmonella typhimurium, with and without plasmid pKM101
    Mutation Research/DNA Repair Reports, vol. 184, no. 1, pp. 13–21, 1987
  144. Morphological transformation and chromosome damage by amsacrine in ? clone 8 cells
    Mutation Research/Genetic Toxicology, vol. 170, no. 3, pp. 133–143, 1986
  145. Chromosome damage by dothistromin in human peripheral blood lymphocyte cultures: a comparison with aflatoxin B1
    Mutation Research/Genetic Toxicology, vol. 170, no. 1-2, pp. 47–53, 1986
  146. Verapamil modulates mutagenicity of antitumour acridines in bacteria and yeast
    Biochemical Pharmacology, vol. 35, no. 24, pp. 4581–4584, 1986
  147. Inverse correlation between bacterial frameshift mutagenicity and yeast mitochondrial effects of antitumour anilinoacridines
    Chemico-Biological Interactions, vol. 56, no. 2-3, pp. 145–155, 1985
  148. Three consistent patterns of response to substituted acridines in a variety of bacterial tester strains used for mutagenicity testing
    Mutation Research/Genetic Toxicology, vol. 157, no. 1, pp. 29–37, 1985
  149. Condensed tannins induce micronuclei in cultured V79 Chinese hamster cells
    Mutation Research/Genetic Toxicology, vol. 158, no. 1-2, pp. 89–95, 1985
  150. Quantitation of free and conjugated bile acids in human feces using a high-pressure liquid chromatography counterion method
    Analytical Biochemistry, vol. 143, no. 2, pp. 325–332, 1984